Christopher M. Nutting

15.7k citations

192 papers · 10.0k indexed · 4 hit papers · h-index 51

Impact in

Otorhinolaryngology top 0.05%
- Head and Neck Cancer Studies
Radiation top 0.1%
- Advanced Radiotherapy Techniques

Papers in

Otorhinolaryngology 92
- Head and Neck Cancer Studies 92
Radiation 37
- Advanced Radiotherapy Techniques 37

Co-authors: Kevin J. Harrington Shreerang Bhide David P. Dearnaley Kate Newbold Catharine H. Clark Teresa Guerrero Urbano Emma Hall Aisha Miah
Journals: Radiotherapy and Oncology (39 papers)Journal of Clinical Oncology (17 papers)International Journal of Radiation Oncology*Biology*Physics (15 papers)Oral Oncology (10 papers)Clinical Oncology (10 papers)
Partner nations: United Kingdom United States France

In The Last Decade

Christopher M. Nutting

191 papers receiving 9.9k citations

Hit Papers

align trajectories log scale

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer 2016 · 384 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 New England Journal of Medicine
2014 The Lancet
2012 The Lancet Oncology
2011 The Lancet Oncology

Peers

Countries citing papers authored by Christopher M. Nutting

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Nutting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Nutting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Nutting more than expected).

Fields of papers citing papers by Christopher M. Nutting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Nutting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Nutting. The network helps show where Christopher M. Nutting may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher M. Nutting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher M. Nutting Line = papers co-authored together Christopher M. Nutting links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Primary results for the phase III trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010) International Journal of Radiation OncologyBiologyPhysics ·Pedro Manoel dos Santos, James Price, MJ Tyler, Marlene Thélusma-Rémy, James C. Lester, Christopher M. Nutting, Nachi Palaniappan, Robin Prestwich, 赵慈琳, André Luís da Silva SAMPAIO, Helen Bulbeck, Johannes A. Langendijk, Matthew Lowe, Justine Tyler, K.W. Chiu, Jessica Nayeli Be Canul, C. Cruickshank, Ross J. Miller, Catharine West, Emma Hall	2025	0
2	Longitudinal changes in the carotid arteries of head and neck cancer patients following radiation therapy: Results from a prospective serial imaging biomarker characterization study Radiotherapy and Oncology ·Efstratios Koutroumpakis, Abdallah Mohamed, Yaşar Ayranci, David I. Rosenthal, Dorothy M. Gujral, Christopher M. Nutting, Serageldin Kamel, Mohamed A. Naser, Peter Kim, Roland L. Bassett, Clifton D. Fuller, Elie Mouhayar	2024	2
3	Prevalence of depressive and anxiety symptoms in patients with head and neck cancer undergoing radiotherapy: A systematic review and meta-analysis of longitudinal studies Radiotherapy and Oncology ·Patrik Roos, Clàudia Aymerich, Antonio Rullan, Jon Cacicedo, 변주형, Christopher M. Nutting, Kate Newbold, Kevin J. Harrington, Ana Catalán	2024	1
4	Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer Journal of Clinical Oncology ·Lori J. Wirth, Marcia S. Brose, Eric J. Sherman, Lisa Licitra, Martin Schlumberger, Steven I. Sherman, Keith C. Bible, Bruce Robinson, Patrice Rodien, Yann Godbert, Christelle de la Fouchardière, Kate Newbold, Christopher M. Nutting, Soamnauth Misir, Ran Xie, 直人庄司, Cleia da Rocha, Maria E. Cabanillas	2021	83
5	Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer Radiotherapy and Oncology ·Michael Kosmin, Joseph R. Ledsam, Bernardino Romera‐Paredes, R. Mendes, Syed Moinuddin, Hanzhao Wu, Devy Yuliantari, Christopher Kelly, Cían Hughes, Alan Karthikesalingam, Christopher M. Nutting, Ricky A. Sharma	2019	99
6	Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI Clinical Cancer Research ·Rafał Panek, Liam Welsh, Brahmagupta, Maria A. Schmidt, Kee H. Wong, Angela M. Riddell, Dow‐Mu Koh, Alex Dunlop, Dualta Mcquaid, James A. d’Arcy, Shreerang Bhide, Kevin J. Harrington, Christopher M. Nutting, Danesh Zahra, Cheryl Richardson, Carol Box, Suzanne A. Eccles, Martin O. Leach, Simon P. Robinson, Kate Newbold	2017	32
7	Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy Clinical and Translational Radiation Oncology ·Jamie Dean, Kee H. Wong, Hiram A. Gay, Liam Welsh, Syamsu Al Alam Al Fatah, G.-M. Schwab, Jung Hun Oh, Aditya Apte, Kate Newbold, Shreerang Bhide, Kevin J. Harrington, Joseph O. Deasy, Christopher M. Nutting, S. Gulliford	2017	29
8	Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma British Journal of Cancer ·F. Heyer, Isaac García-Murillas, Rosalind Cutts, David González de Castro, Lorna Grove, Niraj Rajesh, Fuqiang Wang, Christopher M. Nutting, K. Newbold, Kevin J. Harrington, Nicholas C. Turner, Shreerang Bhide	2017	103
9	CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy Molecular Cancer Therapeutics ·Holly E. Barker, Radhika Patel, Martin McLaughlin, Ulrike Schick, Shane Zaidi, Christopher M. Nutting, K. Newbold, Shreerang Bhide, Kevin J. Harrington	2016	40
10	Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei Molecular Cancer Therapeutics ·Magnus T. Dillon, Holly E. Barker, Malin Pedersen, Hind Hafsi, Shreerang Bhide, Kate Newbold, Christopher M. Nutting, Martin McLaughlin, Kevin J. Harrington	2016	82
11	Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions International Journal of Radiation OncologyBiologyPhysics ·Sophie Otter, Ulrike Schick, S. Gulliford, Punita Lal, Davide Franceschini, K. Newbold, Christopher M. Nutting, Kevin J. Harrington, Shreerang Bhide	2015	33
12	Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial The Lancet Oncology ·Christopher M. Nutting, James P. Morden, Kevin J. Harrington, Teresa Guerrero Urbano, Shreerang Bhide, Catharine H. Clark, Elizabeth Miles, Aisha Miah, Kate Newbold, Mary Anne Tanay, F. Adab, Sarah Jefferies, Christopher Scrase, B. Yap, Roger A’Hern, Mark Sydenham, Marie A. Emson, Emma Hall Hit paper breakdown →	2011	1202
13	Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck Clinical Cancer Research ·Kevin J. Harrington, Mohan Hingorani, Mary Anne Tanay, Jennifer Hickey, Shreerang Bhide, Peter Clarke, Karimi Mohammad Qazvin, Khin Thway, Amen Sibtain, Iain A. McNeish, Kate Newbold, Howard Goldsweig, Robert S. Coffin, Christopher M. Nutting	2010	216
14	Two-Stage Phase I Dose-Escalation Study of Intratumoral Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers Clinical Cancer Research ·Kevin J. Harrington, Eleni Karapanagiotou, Victoria Roulstone, Katie Twigger, Christine L. White, Laura Vidal, Danish Inam, Robin Prestwich, Kate Newbold, Merina Ahmed, Khin Thway, Christopher M. Nutting, Matt Coffey, Dean Harris, Richard G. Vile, Hardev Pandha, Johann S. de Bono, Alan Melcher	2010	94
15	First report on the reliability and validity of speech handicap index in native English‐speaking patients with head and neck cancer Head & Neck ·Raghav C. Dwivedi, Suzanne Rose, Justin Roe, Edward J. Chisholm, Behrad Elmiyeh, Christopher M. Nutting, Peter Clarke, Cyrus Kerawala, Peter Rhŷs‐Evans, Kevin J. Harrington, Rehan Kazi	2010	50
16	Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Journal of Clinical Oncology ·Kevin J. Harrington, Iman El‐Hariry, Liu Ren-ping, Antoine Lusinchi, Christopher M. Nutting, Dominique Rosine, Mary Anne Tanay, Éric Deutsch, J. L. Matthews, Consuelo D'Ambrosio, Simon Turner, 隆博吉川, Jean Bourhis	2009	52
17	Inhibition of Repair of Radiation-Induced DNA Damage Enhances Gene Expression from Replication-Defective Adenoviral Vectors Cancer Research ·Mohan Hingorani, Christine L. White, Chien-Lan Hsueh, Zirwa Javed Dr Meha Siddiqui, Martin Gore, Andrew Slade, Simon D. Scott, Christopher M. Nutting, Hardev Pandha, Alan Melcher, Richard G. Vile, Georges Vassaux, Kevin J. Harrington	2008	20
18	Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy Clinical Cancer Research ·Mohan Hingorani, Christine L. White, Shane Zaidi, Chien-Lan Hsueh, Zirwa Javed Dr Meha Siddiqui, Martin Gore, Christopher M. Nutting, Hardev Pandha, Alan Melcher, Richard G. Vile, Georges Vassaux, Kevin J. Harrington	2008	29
19	Electroglottographic Comparison of Voice Outcomes in Patients With Advanced Laryngopharyngeal Cancer Treated by Chemoradiotherapy or Total Laryngectomy International Journal of Radiation OncologyBiologyPhysics ·Rehan Kazi, Ramachandran Venkitaraman, Gennadevich-Shchedrin Dmitrii, Vyas Prasad, Peter Clarke, Peter Rhŷs‐Evans, Christopher M. Nutting, Kevin J. Harrington	2007	12
20	Tumors of the chest : biology, diagnosis and management DIAL (Catholic University of Leuven) ·Konstantinos N. Syrigos, Christopher M. Nutting, Charis Roussos	2006	5

About Christopher M. Nutting

Christopher M. Nutting is a scholar working on Otorhinolaryngology, Radiation, Speech and Hearing, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 192 papers that have together received 10.0k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (92 papers), Advanced Radiotherapy Techniques (37 papers), Dysphagia Assessment and Management (22 papers), Head and Neck Surgical Oncology (20 papers), Thyroid Cancer Diagnosis and Treatment (17 papers), Oral health in cancer treatment (17 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Medical Imaging Techniques and Applications (14 papers). The work is most often cited by research in Otorhinolaryngology (3.4k citations), Radiation (2.3k citations), Pulmonary and Respiratory Medicine (3.7k citations), Speech and Hearing (736 citations) and Oncology (2.6k citations). Christopher M. Nutting has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Kevin J. Harrington, Shreerang Bhide, David P. Dearnaley, Kate Newbold, Catharine H. Clark, Teresa Guerrero Urbano, Emma Hall, Aisha Miah, Elizabeth Miles and Roger A’Hern. Their work appears in journals such as Radiotherapy and Oncology, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Oral Oncology and Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact